tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Justin Zelin, 40 are a BUY (95.24%), 2 are a HOLD (4.76%).
Analyst Justin Zelin, currently employed at BTIG, carries an average stock price target met ratio of 25.52% that have a potential upside of 32.5% achieved within 94 days.
Justin Zelin’s has documented 77 price targets and ratings displayed on 17 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on JSPR, Jasper Therapeutics at 08-Jan-2025.
Analyst best performing recommendations are on ABEO (ABEONA THERAPEUTICS).
The best stock recommendation documented was for ABEO (ABEONA THERAPEUTICS) at 11/11/2020. The price target of $75 was fulfilled within 89 days with a profit of $42.5 (130.77%) receiving and performance score of 14.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$15
$9.76 (186.26%)
$15
3 months 6 days ago
(25-Nov-2024)
0/6 (0%)
$9.06 (152.53%)
Buy
$18
$12.76 (243.51%)
$18
4 months 2 days ago
(29-Oct-2024)
1/5 (20%)
$11.43 (173.97%)
61
Hold
$6
$0.76 (14.50%)
$25
2 years 3 months 17 days ago
(14-Nov-2022)
1/2 (50%)
$1.85 (44.58%)
452
Buy
$75
$70.79 (1681.47%)
$50
4 years 3 months 21 days ago
(11-Nov-2020)
2/3 (66.67%)
$45.92 (117.11%)
101
Buy
$22
4 years 9 months 23 days ago
(08-May-2020)
1/3 (33.33%)
$-59.25 (-72.92%)
820
Which stock is Justin Zelin is most bullish on?
Which stock is Justin Zelin is most reserved on?
What Year was the first public recommendation made by Justin Zelin?
